Drug details

Adbry (tralokinumab-ldrm for injection)

type of Interleukin Inhibitors

Adbry (tralokinumab-ldrm) is a human IgG4 monoclonal antibody indicated for the treatment of moderate-to-severe atopic dermatitis in adult patients whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. 

This drug may have the following side effects:

• lightheadedness,
• itching,
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• fainting, 
• skin rash, and
• severe dizziness, 
• changes in vision

The following drugs are related to Adbry, either as a replacement or used together:

• Otezla (apremilast tablets)
• Bryhali (halobetasol propionate lotion)
• Clobex Lotion (clobetasol propionate lotion)
• Clobex Shampoo (clobetasol propionate shampoo)
• Clobex Spray (clobetasol propionate spray)
• Eucrisa Ointment (crisaborole)
• Cutivate Cream (fluticasone topical)
• Cutivate Lotion (fluticasone propionate lotion)
• Cutivate Ointment (fluticasone propionate ointment)
• Dupixent (dupilumab injection)
• Elidel (pimecrolimus cream)
• Protopic (tacrolimus)
• Skyrizi (risankizumab-rzaa injection)
• Triamcinolone Cream (triamcinolone acetonide cream)
• Triamcinolone Lotion (triamcinolone acetonide lotion)
• Triamcinolone Ointment (triamcinolone acetonide ointment)